Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    "Endometrial stromal sarcoma"
Show Display Options
Rank Status Study
1 Completed
Has Results
Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Conditions: Adrenocortical Adenoma;   Endometrial Stromal Sarcomas
Interventions: Procedure: MRI, CT or ultrasound was permitted if MRI was contraindicated;   Procedure: Dexamethasone Supression Test;   Procedure: Sonogram;   Procedure: Biopsy;   Drug: BGG492
2 Completed Mifepristone for Patients With Endometrial Cancer and LGESS
Condition: Endometrial Cancer
Intervention: Drug: Mifepristone
3 Completed
Has Results
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
Conditions: Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Liposarcoma;   Adult Malignant Fibrous Histiocytoma;   Adult Rhabdomyosarcoma;   Dermatofibrosarcoma Protuberans;   Endometrial Stromal Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Uterine Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma;   Uterine Leiomyosarcoma
Intervention: Drug: saracatinib
4 Not yet recruiting A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Conditions: Soft Tissue Sarcoma;   Bone Sarcoma;   Chondrosarcoma;   Gastrointestinal Stromal Sarcoma;   Ewing's Tumor Metastatic;   Ewing's Tumor Recurrent;   Osteosarcoma;   Desmoplastic Small Round Cell Tumor
Interventions: Drug: Ipilimumab;   Drug: Nivolumab
5 Active, not recruiting Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Adenosquamous Carcinoma;   Endometrial Clear Cell Adenocarcinoma;   Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation;   Endometrial Serous Adenocarcinoma;   Endometrioid Stromal Sarcoma;   Recurrent Uterine Corpus Carcinoma
Intervention: Biological: Trebananib
6 Completed Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Borderline Ovarian Clear Cell Tumor;   Borderline Ovarian Serous Tumor;   Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Childhood Embryonal Rhabdomyosarcoma;   Childhood Malignant Ovarian Germ Cell Tumor;   Endometrioid Stromal Sarcoma;   Gestational Trophoblastic Tumor;   Malignant Mesothelioma;   Malignant Ovarian Epithelial Tumor;   Melanoma;   Neoplasm of Uncertain Malignant Potential;   Ovarian Brenner Tumor;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Paget Disease of the Vulva;   Recurrent Cervical Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Vaginal Carcinoma;   Recurrent Vulvar Carcinoma;   Stage I Ovarian Cancer;   Stage I Uterine Corpus Cancer;   Stage I Vaginal Cancer;   Stage I Vulvar Cancer;   Stage IA Cervical Cancer;   Stage IA Fallopian Tube Cancer;   Stage IA Ovarian Cancer;   Stage IA Ovarian Germ Cell Tumor;   Stage IB Cervical Cancer;   Stage IB Fallopian Tube Cancer;   Stage IB Ovarian Cancer;   Stage IB Ovarian Germ Cell Tumor;   Stage IC Fallopian Tube Cancer;   Stage IC Ovarian Cancer;   Stage IC Ovarian Germ Cell Tumor;   Stage II Ovarian Cancer;   Stage II Uterine Corpus Cancer;   Stage II Vaginal Cancer;   Stage II Vulvar Cancer;   Stage IIA Cervical Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Cancer;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIB Cervical Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Cancer;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Cancer;   Stage IIC Ovarian Germ Cell Tumor;   Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor;   Stage III Cervical Cancer;   Stage III Uterine Corpus Cancer;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Primary Peritoneal Cancer;   Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer;   Stage IV Uterine Corpus Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer;   Stage IVB Vulvar Cancer;   Uterine Corpus Cancer;   Uterine Corpus Leiomyosarcoma;   Vulvar Squamous Cell Carcinoma
Intervention: Other: Laboratory Biomarker Analysis
7 Completed Chemotherapy in Treating Patients With Sarcoma of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: pegylated liposomal doxorubicin hydrochloride
8 Completed Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Radiation: radiation therapy
9 Terminated
Has Results
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Condition: Cancer
Interventions: Drug: cyproheptadine hydrochloride;   Other: placebo
10 Completed BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Conditions: Breast Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Melanoma (Skin);   Ovarian Cancer;   Sarcoma
Interventions: Drug: BI 2536;   Other: high performance liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study
11 Completed
Has Results
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Conditions: Adult Malignant Fibrous Histiocytoma of Bone;   Desmoid Tumor;   Endometrial Cancer;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: sunitinib malate
12 Completed Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: perifosine
13 Completed STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: imatinib mesylate
14 Completed Thalidomide in Treating Patients With Gynecologic Sarcomas
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: thalidomide
15 Completed Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Brain and Central Nervous System Tumors;   Endometrial Cancer;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: trabectedin
16 Unknown  Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Drug: temozolomide
17 Completed Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Conditions: Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma
Interventions: Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride
18 Completed Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Metastatic Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: conventional surgery
19 Completed Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: isolated perfusion;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
20 Completed Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Condition: Life Threatening Diseases
Intervention: Drug: Imatinib mesylate

Study has passed its completion date and status has not been verified in more than two years.